These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 2966091)

  • 1. Detection of new MHC mutations in mice by skin grafting, tumor transplantation and monoclonal antibodies: a comparison.
    Egorov IK; Egorov OS
    Genetics; 1988 Feb; 118(2):287-98. PubMed ID: 2966091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presensitization by skin grafting from major histocompatibility complex class I or major histocompatibility complex class II deficient mice identifies class I antigens as inducers of allosensitization.
    Qian S; Fu F; Li Y; Gao L; Lu L; Noyola H; Rao AS; Thomson AW; Fung JJ
    Immunology; 1995 May; 85(1):82-7. PubMed ID: 7635525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of RT1gv1: a new rat MHC haplotype isolated from the wild.
    Begovich AB; Ziebur J; Gasser DL
    Immunogenetics; 1984; 20(2):205-9. PubMed ID: 6236148
    [No Abstract]   [Full Text] [Related]  

  • 4. Cloning of self-major histocompatibility complex antigen-specific suppressor cells from adult bone marrow.
    Takahashi T; Mafune K; Maki T
    J Exp Med; 1990 Sep; 172(3):901-9. PubMed ID: 2143775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MHC-specific graft-protective and delayed-type hypersensitivity (DTH) suppressive activity of a CD4+ CD8+, alpha beta T cell receptor (TCR) positive lymphoma isolated from a tolerant mouse.
    Jánossy T; Baranyi L; Knulst AC; Vizler C; Benner R; Végh P
    Immunobiology; 1993 Jun; 188(1-2):172-93. PubMed ID: 8406557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xenogeneic iso-skin graft and mixed lymphocyte reaction studies using HLA-DP transgenic mice.
    Hagihara M; Shimura T; Takebe K; Munkhbat B; Sato T; Tsuchida F; Sato K; Tsuji K
    Transpl Immunol; 1996 Sep; 4(3):220-6. PubMed ID: 8893453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic characterization of FLA, the cat major histocompatibility complex.
    Winkler C; Schultz A; Cevario S; O'Brien S
    Proc Natl Acad Sci U S A; 1989 Feb; 86(3):943-7. PubMed ID: 2492667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-gamma is necessary for initiating the acute rejection of major histocompatibility complex class II-disparate skin allografts.
    Ring GH; Saleem S; Dai Z; Hassan AT; Konieczny BT; Baddoura FK; Lakkis FG
    Transplantation; 1999 May; 67(10):1362-5. PubMed ID: 10360591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor allograft rejection is mainly mediated by CD8+ cytotoxic T lymphocytes stimulated with class I alloantigens in cooperation with CD4+ helper T cells recognizing class II alloantigens.
    Tomita Y; Mayumi H; Eto M; Nomoto K
    J Immunol; 1990 Mar; 144(6):2425-35. PubMed ID: 1968930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of MHC-I mRNA in peripheral blood lymphocytes as an early marker of acute rejection following skin transplantation in mice.
    Wan F; Lu N; Zou X; Zhang Y; Shan N; Yang X; Li X; Zhao S; Wang S; Zhu M; Li X; Li Y; Zhou Y; Li H
    Tohoku J Exp Med; 2008 May; 215(1):79-87. PubMed ID: 18509238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo targeting of an anti-tumor antibody coupled to antigenic MHC class I complexes induces specific growth inhibition and regression of established syngeneic tumor grafts.
    Donda A; Cesson V; Mach JP; Corradin G; Primus FJ; Robert B
    Cancer Immun; 2003 Aug; 3():11. PubMed ID: 12916958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
    Tremblay N; Fontaine P; Perreault C
    Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iat epitopes on T cell receptor for self MHC class II determinants.
    Uracz W
    Folia Biol (Praha); 1988; 34(6):356-71. PubMed ID: 2470623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bidirectional blockade of CD4 and major histocompatibility complex class II molecules: an effective immunosuppressive treatment in the mouse heart transplantation model.
    Ito H; Hamano K; Fukumoto T; Wood KJ; Esato K
    J Heart Lung Transplant; 1998 May; 17(5):460-9. PubMed ID: 9628564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of MHC class I or class II "knock out" mice to investigate the role of these antigens in allosensitization.
    Qian S; Fu F; Li Y; Gao L; Lu L; Noyola H; Rao AS; Thomson AW; Demetris AJ; Starzl TE
    Transplant Proc; 1995 Feb; 27(1):475-6. PubMed ID: 7879067
    [No Abstract]   [Full Text] [Related]  

  • 16. Murine major histocompatibility complex class-I mutants: molecular analysis and structure-function implications.
    Nathenson SG; Geliebter J; Pfaffenbach GM; Zeff RA
    Annu Rev Immunol; 1986; 4():471-502. PubMed ID: 3518748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Searching for MHC-restricted anti-viral antibodies: antibodies recognizing the nucleoprotein of influenza virus dominate the serological response of C57BL/6 mice to syngeneic influenza-infected cells.
    Tamminen WL; Wraith D; Barber BH
    Eur J Immunol; 1987 Jul; 17(7):999-1006. PubMed ID: 3497045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4 T cells can reject major histocompatibility complex class I-incompatible skin grafts.
    Wise M; Zelenika D; Bemelman F; Latinne D; Bazin H; Cobbold S; Waldmann H
    Eur J Immunol; 1999 Jan; 29(1):156-67. PubMed ID: 9933097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular basis of skin allograft rejection across a class I major histocompatibility barrier in mice depleted of CD8+ T cells in vivo.
    Rosenberg AS; Munitz TI; Maniero TG; Singer A
    J Exp Med; 1991 Jun; 173(6):1463-71. PubMed ID: 1674524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mixed allogeneic reconstitution (A+B----A) to induce donor-specific transplantation tolerance. Permanent acceptance of a simultaneous donor skin graft.
    Ildstad ST; Wren SM; Oh E; Hronakes ML
    Transplantation; 1991 Jun; 51(6):1262-7. PubMed ID: 1828637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.